Every major AI lab wants exposure to drug discovery. OpenAI now joins Anthropic, Google and co in acquisitions that give them access to…
About SN68 NOVA
METANOVA LABS@metanova_labsEvery major AI lab wants exposure to drug discovery. OpenAI now joins Anthropic, Google and co in acquisitions that give them access to pharma upside. If Bittensor is to become the decentralized analogue it needs it too. NOVA is that piece of the puzzle.
Quoting @OpenAI
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner. Welcome @ashokaraj_ and team! openai.com/index/openai-to-acquire-orchestra-bi…
SN68 NOVA at a glance
SN68, NOVA (α token ظ), is one of the independent markets on the Bittensor network, each with its own α token and its own price. Its α currently trades at 0.016675 τ (≈ $4.60), against 39,547 τ of pool liquidity. On-chain, the best-delegated validator on it yields about 35.95% APR (simple) and 43.26% APY (compounded), emissions add 0.002325 τ to the pool each block, epochs run every 360 blocks. It was registered at block #4,972,413.
Taosis newsletters
Taosis News: the week’s articles from the subnet teams, the press and community newsletters, every Friday. Taosis Weekly: the week’s movers, best yields and chain events, with dollar values, every Monday. Past issues
More from SN68 NOVA
Taosis indexes announcements, articles, posts and releases about Bittensor subnets from their own channels and keeps a record of each. The text above is the source’s; the figures are read from the chain by Taosis.